Alto Ingredients (ALTO) Tops Q2 EPS by 6c

Alto Ingredients (NASDAQ: ALTO) reported Q2 EPS of $0.15, $0.06 better than the analyst estimate of $0.09. Revenue for the quarter came in at $245.7 million versus the consensus estimate of $231.22 million.

For earnings history and earnings-related data on Alto Ingredients (ALTO) click here.

You May Also Be Interested In

• Bessent: We Make A Market Buying Older Bonds
• Ionis Pharmaceuticals (IONS) PT Lowered to $84 at Raymond James
• B.Riley on Viking Therapeutic (VKTX): 'we continue to see an attractive setup'